Skip to content
NAPP offices

It’s not just our medicines that need to pass the quality test.

We’re in the business of bringing medicines to the NHS. It is work that deeply affects the lives of health providers and patients – and here at Napp we pride ourselves on doing it the right way.

Napp have a strong track record in bringing high quality, innovative medicines to UK health professionals and their patients. We believe in excellence and delivering on our promises to the NHS, patients, our business partners and each other.

We strive to offer new medicines and initiatives that meet genuine needs, make a positive difference to patients’ lives and support the NHS in delivering effective, high-quality, sustainable healthcare.

 

*Once you click on this link you will leave this site to go to the Napp promotional website. Please click ‘Continue to external link’ if you want to proceed.

© 2024 NAPP PHARMACEUTICALS LIMITED. DOP: July 2024 UK-CORP-2200003 v10.0

Opioid Charter

For Mundipharma’s Charter on the responsible medical use of opioid analgesics in pain management click here.

Opioid Safety Statement

“Attention should be given as the use of opioids has a risk of addiction, misuse and abuse. Therefore, appropriate assessment and monitoring is a requirement at initiation, maintenance and tapering down of opioid therapy.”